COGm Analysis for an Allo Drug Product Process with a Focus on Optimizing Cost/Dose
Time: 3:00 pm
day: Conference Day Two
Details:
- Design and cost drivers of a commercial scale allogeneic process
- Cell expansion is a key driver of cost/dose
- Path to manufacturing allogeneic therapy at <$1000/dose
- Process scaling from Phase I through Pivotal and commercial
